*ST Haiyi retired, losing money for years, and actual controllers for several months

After repeated reminding the company's stock may be terminated, on the evening of June 20,*ST Haizhui (600896.SH, that is, Lanhai Medical) received the decision to terminate the listing of the company's stock and the China Securities Regulatory Commission Hainan Supervision Bureau "Decision of Administrative Regulatory Measures".

On June 28, 2022,*ST Haizheng will enter the delisting period. It is expected that the final transaction date will be on July 18, 2022. The actual controller Michunlei suspected that he had lost contact for several months.

Losses for the year,*ST Haizheng finally delisted

Regarding the main reasons for the termination of listing, the announcement pointed out that due to the negative value of the audited net profit in 2020 and the operating income below RMB 100 million,*ST Haiyi has been implemented from May 6, 2021 to be implemented by delisting risks. Warning, on April 30, 2022,*ST Haizheng disclosed the annual report of 2021, and the 2021 financial report was issued a audit report for reserved opinions.

Public information shows that*ST Haizheng is mainly engaged in the investment construction and operation management of high -end medical projects. The company's predecessor was Zhonghai Haisheng. In 2015, Michun Lei spent 3 billion yuan to become the company's actual controller. After obtaining control, Mi Chunlei began to build a medical and health strategic platform, renamed China Sea Haisheng as the medical treatment, and peeled all the shipping assets. It laid out the business of high -end rehabilitation hospitals, high -end medical clinics, and online hospitals.

However, there are only three projects currently operating in the operation of *ST Haiyi, including the prevalent clinics, Yiyuanhai clinics, and the rehabilitation hospital of the sea. It was -178 million yuan, 57.966 million yuan, -285 billion yuan.

After the 2021 annual report disclosure, Luanhai Medical said that its profits were mainly influencing the company's medical service operations profit and loss, and the company's 44%equity plan for Henfeng Hospital was prepared for large impairment preparations.

Lanhai Medical said that due to the excessive investment cost of Hefeng Hospital, the shareholders' financial support has great uncertainty, and the financing capacity of Hefeng Hospital is also seriously insufficient. Lanhai Medical Preparation for the impairment of 44 % of the long -term equity investment in Hefeng Hospital was 157 million yuan.

Hefeng Hospital was acquired in 2016 for*ST Haiyi in 2016. At that time,*ST Haiyi said that he would have some medical property assets of the central hospital (original) of Huangpu District (original) of Hefeng Real Estate (formerly Hefeng Hospital). Update and transform, open an international high -end comprehensive hospital in the central urban area of ​​Shanghai.

However, in November 2020, due to the expected project progress,*ST Haiyi and the controlling shareholder Shanghai Lanhai signed an agreement to transfer 51 % equity of Shanghai Hefeng Hospital and 512 million yuan of 512 million yuan of claims to Shanghai , Intended to "blood transfusion" of the controlling shareholder.

In order to confirm the relevant creditor's rights, the company signed the "Loan Agreement" with Hefeng Hospital, which agreed that the repayment period of the remaining loan was one year after the transaction was completed. *ST Haiyi completed the asset transfer procedures for 51%of the equity of Hefeng Hospital on January 25, 2021. The above claims have expired on January 24, 2022, but*ST Haisao failed to recover in time, and did not announce the announcement of the issuance of the issuance of the debt in time.

The actual controller lost contact, and a number of executives such as Mi Chunlei received a warning letter

On the day of the release of the announcement of the announcement of the listing,*ST Haizheng also issued an announcement saying that it received the "Administrative Regulatory Measures Decisions" issued by the Hainan Securities Regulatory Bureau. According to the relevant provisions of the "Administrative Measures for the Information Disclosure of Listed Companies", the Hainan Securities Regulatory Bureau decided to take the company's chairman Mi Chunlei, then executive vice president and chief financial officer, financial director Cai Zehua, and the secretary of the board of directors He Yongxiang. And record in the capital market integrity information database.

It is worth mentioning that it was out of contact a few months ago.

At the beginning of the year, the*ST sea doctor announced that Mi Chunlei authorized to see the director of the Haidi Medical Directors Ni Xiaowei to fulfill the duties of chairmanship, and the period was 3 months. On April 12,*ST Haiyi stated that he once again received a written authorization issued by the chairman Mi Chunlei. At the end of the month,*ST Haizheng stated in a regulatory reply letter that the company could not get timely contact with Miya Lei in a timely manner.

Michri was born in Chongming, Shanghai. On the Hurun Rich List in 2021, Michri ranked 647 yuan for RMB 11 billion. Its current chairman of the Lanhai Group, chairman of Shanghai Lanhai Investment, Shanghai Laida Life Medical Acts and Executive Directors, Chairman of Shanghai Life Insurance, and Chairman of Lanhai Medical.

In 2003, Mi Chunlei and his father Mi Boyuan contributed 40 million yuan and 10 million yuan, respectively, and established Shanghai Zhongying Enterprise Development Co., Ltd. After seven capital increase and shareholding, the registered capital has increased from the initial 50 million yuan to 6.5 billion yuan. The tentacles of business investment have continued to extend to insurance, banks, real estate, medical care, automobiles, coal mines and other fields.

According to Caixin report, Michri was taken away by the local economic investigation department at the end of December 2021. About two weeks later, the investment director of Shanghai Life was also taken away.

- END -